Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06761066
NA

Efficacy and Safety of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Sponsor: NVP Healthcare

View on ClinicalTrials.gov

Summary

The purpose of this clinical trial is to exploratively evaluate the efficacy and safety of NVP -NK4146 in improving mild cognitive impairment (MCI) in patients with due to Alzheimer's disease (AD) compared to placebo

Official title: 36-week, Single-center, Randomized, Double-blind, Parallel-design, Placebo-controlled Trial to Determine the Safety and Efficacy of NVP-NK4146 in Patients With Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Key Details

Gender

All

Age Range

60 Years - Any

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-01-20

Completion Date

2027-12-30

Last Updated

2026-09-01

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

NVP-NK4146

BID for 36 weeks orally

DIETARY_SUPPLEMENT

NVP-NK4146 Placebo

BID for 36 weeks orally

Locations (1)

The Catholic University of Korea Yeouido St. Mary's Hospital

Seoul, South Korea